198 completed, 53 unknown, 43 recruiting, 31 not yet recruiting. 154 Not applicable, 51 Phase 3, 43 Phase 4, 39 Phase 2, 25 Phase 1.
Follow Benign Prostatic Hyperplasia: new trials by email Literature Review of Benign Prostatic Hyperplasia trials Research Report on Benign Prostatic Hyperplasia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ceasing Alpha-blockers Early After Resection of the Prostate (The CLEAR Trial) Tamsulosin hydrochloride 0.2 mg, Placebo - Benign Prostatic Hyperplasia | Phase 4 | Not yet recruiting | Shanghai East Hospital | 400 | 2026-12-01 | 2026-09-29 |
| Anterior Bridge-Preserving Versus Conventional Early Apical Release in Bipolar Enucleation of the Prostate Anterior Bridge-Preserving Semicircular Early Apical Release (ABP-S-EAR), Conventional Early Apical Release (EAR) - Benign Prostatic Hyperplasia, Benign Prostatic Obstruction | Not applicable | Not yet recruiting | Benha University | 230 | 2026-11-30 | 2026-10-26 |
| Anterior Bridge-Preserving Versus Conventional Early Apical Release During Holmium Laser Enucleation of the Prostate Anterior Bridge-Preserving Semicircular Early Apical Release (ABP-S-EAR), Conventional Early Apical Release (EAR) - Benign Prostatic Hyperplasia, Benign Prostatic Obstruction | Not applicable | Not yet recruiting | Ahmed Ebrahim Zahran | 230 | 2026-11-30 | 2026-10-23 |
| A Study to Track the Safety of Vesomni in Men in South Korea Treated in Routine Clinical Practice for the Urinary Symptoms of Benign Prostatic Hyperplasia (Enlarged Prostate) Vesomni - Benign Prostatic Hyperplasia | Not yet recruiting | Astellas Pharma Korea, Inc. | 600 | 2026-11-30 | 2026-10-15 | |
| Efficacy and Safety of Combination Therapy Compared With Monotherapy in Patients With Benign Prostatic Hyperplasia Finasteride 5 mg Tablet, single dose, Tamsulosin 0.4Mg Capsule - Benign Prostatic Hyperplasia | Phase 3 | Not yet recruiting | Il-Yang Pharm. Co., Ltd. | 660 | 2026-11-09 | 2026-10-13 |
| Modified SOLTIVE Study SOLTIVE Premium SuperPulsed Laser System - Calculi, Renal, Calculi, Urinary | Not yet recruiting | Olympus Corporation of the Americas | 250 | 2026-11-01 | 2026-10-05 | |
| Prostatic Artery Embolization Using Histoacryl as a Novel Embolizing Agent for Treatment of BPH Prostatic Artery Embolization with N-butyl Cyanoacrylate - Benign Prostatic Hyperplasia, Lower Urinary Tract Symptoms | Not applicable | Not yet recruiting | Assiut University | 30 | 2026-11-01 | 2026-10-29 |
| Ultrasound-Guided vs. Conventional Prostate Suspension in BPH: An Exploratory Study Ultrasound-Guided Prostatic Urethral Lift, Conventional Prostatic Urethral Lift - Benign Prostatic Hyperplasia | Not applicable | Not yet recruiting | Shanghai East Hospital | 20 | 2026-10-01 | 2026-10-14 |
| Vivifi Device Safety Evaluation for the Treatment of Benign Prostatic Hyperplasia Minimally invasive percutaneous ablation - Benign Prostatic Hyperplasia | Not applicable | Not yet recruiting | Vivifi Medical | 20 | 2026-09-01 | 2026-08-04 |
| Selective Median Lobe Surgery Outcomes Study Selective Median Lobe TURP, Selective Median Lobe HoLEP/AEEP - Benign Prostatic Hyperplasia, Lower Urinary Tract Symptoms (LUTS) in Men With Benign Prostatic Hyperplasia (BPH) | Not yet recruiting | Necmettin Erbakan University | 420 | 2026-09-01 | 2026-07-13 | |
| Pupil Size and Choroidal Thickness Changes With Tamsulosin vs. Silodosin in Benign Prostatic Hyperplasia Patients tamsulosin 0.4mg, Silodosin 8 mg - Benign Prostatic Hyperplasia, Silodosin | Phase 4 | Not yet recruiting | Mohsen Pourazizi | 40 | 2026-08-01 | 2026-08-03 |
| Iris Structural Changes With Tamsulosin vs. Silodosin in Benign Prostatic Hyperplasia Patients tamsulosin 0.4mg, Silodosin 8 mg - Benign Prostatic Hyperplasia, Tamsulosin | Phase 4 | Not yet recruiting | Mohsen Pourazizi | 40 | 2026-08-01 | 2026-08-03 |
| Emsella for Reducing tSUI After HOLEP Emsella chair - Benign Prostatic Hyperplasia, Enlarged Prostate With Lower Urinary Tract Symptoms | Not applicable | Enrolling by invitation | Northwestern University | 30 | 2026-07-24 | 2026-10-15 |
| MRI-DTI Assessment of Urethral Internal Sphincter Ring and Prostate Base Morphology Urethral Internal Sphincter Morphology, Benign Prostatic Hyperplasia | Recruiting | Jiangsu Taizhou People's Hospital | 80 | 2026-07-15 | 2026-07-20 | |
| Tamsulosin Monotherapy Versus Combination Therapy With Tadalafil (2.5 mg vs 5 mg) in Managing Male LUTS Secondary to BPH Tamsulosin 0.4 mg + Tadalafil 2.5 mg, Tamsulosin 0.4 mg + Tadalafil 5 mg, Tamsulosin 0.4 mg - Safety, Efficacy | Not applicable | Recruiting | Ain Shams University | 90 | 2026-07-01 | 2026-07-23 |
| Thulium Laser Enucleation With Bladder Neck Incision for Small-Volume Benign Prostatic Hyperplasia Thulium Laser Enucleation of the Prostate Combined With Bladder Neck Incision, Thulium Laser Enucleation of the Prostate, Transurethral Resection of the Prostate - Benign Prostatic Hyperplasia, Bladder Outlet Obstruction | Not applicable | Not yet recruiting | Chinese PLA General Hospital | 932 | 2026-07-01 | 2026-07-21 |
| ExMI vs. Biofeedback PFMT for Post-Prostatectomy Incontinence Extracorporeal Magnetic Stimulation (ExMI), Pelvic Floor Muscle Training (PFMT) - Post-Prostatectomy Urinary Incontinence, Benign Prostatic Hyperplasia | Not applicable | Active not recruiting | Tanta University | 100 | 2026-07-01 | 2026-07-13 |
| A Clinical Trial to Evaluate the Bioequivalence of AD-116A Compared to AD-1161 in Healthy Adult Male Volunteers AD-116A, AD-1161 - Benign Prostatic Hyperplasia | Phase 1 | Not yet recruiting | Addpharma Inc. | 44 | 2026-07-01 | 2026-07-20 |
| A Clinical Trial to Evaluate the Bioequivalence of AD-116A and AD-1161 Under Fed Conditions in Healthy Adult Male Volunteers AD-116A, AD-1161 - Benign Prostatic Hyperplasia | Phase 1 | Not yet recruiting | Addpharma Inc. | 44 | 2026-07-01 | 2026-07-27 |
| Early Electroacupuncture for Post-TURP LUTS Electroacupuncture, Sham Electroacupuncture - Benign Prostatic Hyperplasia | Not applicable | Not yet recruiting | Zhongda Hospital | 144 | 2026-07-01 | 2026-07-30 |
Showing 20 of 379. Sign in to see all of them.
Prostatic Hyperplasia (379) · Lower Urinary Tract Symptoms (81) · Prostatic Neoplasms (23) · Urinary Bladder, Overactive (14) · Urinary Bladder Neck Obstruction (10) · Erectile Dysfunction (8) · Hyperplasia (6) · Prostatic Diseases (6) · Urinary Incontinence (6) · Urinary Retention (5) · Nocturia (4) · Prostatitis (3) · Urinary Incontinence, Stress (3) · Anxiety Disorders (2) · Ejaculatory Dysfunction (2)
Urogenital Diseases (379) · Genital Diseases (378) · Genital Diseases, Male (378) · Male Urogenital Diseases (378) · Prostatic Diseases (373) · Pathological Conditions, Signs and Symptoms (111) · Signs and Symptoms (99) · Urological Manifestations (95) · Female Urogenital Diseases (44) · Female Urogenital Diseases and Pregnancy Complications (44) · Urologic Diseases (42) · Neoplasms (27) · Neoplasms by Site (27) · Urogenital Neoplasms (26) · Urinary Bladder Diseases (25)
Tamsulosin (41) · Tadalafil (23) · Transurethral Resection of Prostate (22) · Dutasteride (17) · silodosin (13) · Finasteride (9) · Solifenacin Succinate (9) · Botulinum Toxins, Type A (8) · alfuzosin (8) · Adrenergic alpha-Antagonists (5) · Doxazosin (5) · Saline Solution (4) · Cystoscopy (3) · Electroacupuncture (3) · PRX302 (3)
Eli Lilly and Company (14) · Samsung Medical Center (11) · GlaxoSmithKline (9) · Beni-Suef University (7) · NeoTract, Inc. (7) · Ain Shams University (6) · Boston Scientific Corporation (6) · PROCEPT BioRobotics (6) · Assistance Publique - Hôpitaux de Paris (5) · Assiut University (5) · Benha University (5) · Health Ever Bio-Tech Co., Ltd. (5) · Northwestern University (5) · University of Kansas Medical Center (5) · Addpharma Inc. (4)
United States (103) · South Korea (40) · Canada (31) · Egypt (29) · France (27) · Italy (24) · China (23) · Germany (16) · Taiwan (14) · United Kingdom (14) · Turkey (Türkiye) (11) · Australia (9) · New Zealand (9) · Russia (8) · Czechia (7)
Kyu-Sung Lee, Ph.D (4) · Claus Roehrborn, MD (3) · Donald Neff (3) · Hazem Elmansy, MD (3) · Peter Gilling, MD (3) · Allan J Pantuck, MD, MS, FACS (2) · Amy E Krambeck, MD (2) · Bilal Chughtai, MD (2) · Chi Fai NG, MD (2)
PMID 26299520, PMID 42265447, PMID 12559262, PMID 21420124, PMID 21791356, PMID 25613154, PMID 25937539, PMID 36273485, PMID 10367836, PMID 10492184, PMID 10675166, PMID 11056488, PMID 11096237, PMID 11111208, PMID 11590294, PMID 11786675, PMID 11832306, PMID 12121722, PMID 12361895, PMID 1279218, PMID 12796668, PMID 12818001, PMID 12837423, PMID 15126771, PMID 15865523, PMID 15918159, PMID 15989444, PMID 16094022, PMID 16467543, PMID 17130393, PMID 1714529, PMID 1719806, PMID 17416453, PMID 18355417, PMID 18461049, PMID 18722631, PMID 18758208, PMID 19012935, PMID 19091352, PMID 19178175, PMID 19409693, PMID 19815265, PMID 20163842, PMID 20238325, PMID 20825758, PMID 20850831, PMID 20963421, PMID 21109344, PMID 21135869, PMID 21251673
2008 (2), U01DK060817 (2), 2015 (1), K12DK111028 (1), P30CA012197 (1), R01DK056199 (1), R01DK124502 (1), R01DK135804 (1)